Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...

Doug Whitney from Seattle appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has ...

Scientists have repaired a natural gateway into the brains of mice, allowing the clumps and tangles associated with Alzheimer ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease ...

Recent Food and Drug Administration approval of the first two blood tests used in detecting Alzheimer’s disease brings hope ...

Researchers at USC have created the first method to noninvasively measure microscopic blood vessel pulses in the human brain.

The new tool is a blood test. The FDA just gave it the green light to help doctors rule out Alzheimer's Disease. Statistics ...

New research from the University of Miami’s Miller School of Medicine has found striking similarities between the brains of ...

Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s ...